ReportWire

Tag: Healthcare

  • RUSH Introduces the Joan and Paul Rubschlager Building

    RUSH Introduces the Joan and Paul Rubschlager Building

    [ad_1]

    Newswise — Patients seeking world-class clinical expertise will soon have a new destination center with the opening of the Joan and Paul Rubschlager Building — home to the RUSH Cancer Center.

    The new $450 million facility was opened for tours and a reception to celebrate its completion on Friday, Jan. 13. The new building is slated to open to patients in early February.

    The Joan and Paul Rubschlager Building will be the premier Chicago area destination for cancer and neuroscience care and provide a wide variety of services, including radiation therapy, infusion therapy, diagnostic imaging, integrative medicine and expanded clinical trials. RUSH Digestive Diseases will begin seeing patients in the building in July 2023.

    The building will help ensure that RUSH provides the kind of care patients want and deserve. It features:

    • Personalized and convenient care — with new and improved features that give patients a health care experience they can’t get anywhere else
    • Design where every detail was developed with patients in mind and décor specifically chosen to promote healing
    • A new industry-leading, first-floor lab that analyzes samples and sends results to providers in minutes
    • Bright, spacious infusion rooms that provide convenience and privacy, with TV monitors and plenty of space for a friend or family member to be with the patient
    • All-gender restrooms
    • An adult changing table
    • Wheelchair storage nooks on each floor of the building
    • A variety of seating options with tables, equipped with charging stations and flexible chair options for patients of all ages and physical abilities
    • Convenient parking
    • Streamlined check-in areas
    • Chicago skyline views from many patient treatment rooms

    “RUSH has a bold vision for the future focused on providing care in convenient ways that patients want and need, in their communities, in their homes and on their mobile devices. The Joan and Paul Rubschlager Building reflects RUSH’s commitment to excellence and innovation,” said Dr. Omar Lateef, CEO of RUSH.

    “RUSH has grown and now reaches from downtown Chicago to Aurora, across suburban communities and to Northwest Indiana, to offer convenient access to the highest level of care to patients where and when they need it. This facility will serve as a hub for much of this care, and it was built around what patients tell us is most important to them.”

    U.S. Sen. Dick Durbin took part in Friday’s event. 

    “RUSH continues to deliver cutting-edge, personalized treatment for a range of different cancers and brain conditions,” he said. “And thanks to federal investments that help make the new Rubschlager Building possible, researchers and clinicians will be able to expand their state-of-the-art treatment and research efforts for patients. This new site will build on RUSH’s legacy of caring for the community, and I’ll continue advocating for the resources they need to save more lives.”

    Located at the northeast corner of Ashland Avenue and Harrison Street on Chicago’s near West Side, the Joan and Paul Rubschlager Building is directly connected to a new, six-story, 900-space enclosed parking garage, as well as a fourth-floor walkway joining it to the Joan and Paul Rubschlager Tower on the other side of Ashland Avenue. Each floor of the garage is named after a neighborhood on Chicago’s West Side, celebrating the RUSH commitment to the health and wellness of the community.

    The RUSH Cancer Center will care for 127,000 patients by 2027, a nearly 50% increase over current numbers. Consistently ranked among the nation’s best, the RUSH Cancer Center will provide the most advanced cancer care, including nearly 40 cancer care services.

    Among the many elements that place the patient at the center of their care needs, the RUSH Cancer Center will offer private rooms for patients receiving infusions. The security and comfort of these spaces was a priority for designers of the new building, given how much time patients often spend in them.

    The Joan and Paul Rubschlager Building will also house many of RUSH Neurosciences’ highly ranked programs, including neurology and neurosurgery, brain tumor and epilepsy and stroke care and general neurology. RUSH Digestive Diseases, endoscopy and nutrition, as well as RUSH Physical Medicine and Rehabilitation, RUSH Plastic Surgery and the RUSH Lung Center also have a home in the new building.

    The enhancements to the delivery of care were born out of a series of patient focus groups that made it clear that comfort, privacy and infection prevention were priorities for them. Optimizing the patient experience was the primary driver of the building’s design as planners approached the project beginning in 2019.

    Understanding that many patients need lab tests like blood draws before appointments, RUSH placed the laboratory on the first floor, adjacent to the lobby, to allow patients to stop there first.  The building will include the latest in lab technology, which allows blood samples to be analyzed quickly on site. This innovation improves patient care by providing accurate, timely information to guide effective treatment decisions and help clinicians diagnose complex cases.

    [ad_2]

    Rush University Medical Center

    Source link

  • Consider risks and alternatives before deciding on LASIK surgery, UT Southwestern ophthalmologists say

    Consider risks and alternatives before deciding on LASIK surgery, UT Southwestern ophthalmologists say

    [ad_1]

    Newswise — DALLAS – Jan. 13, 2023 – Patients considering LASIK vision correction surgery should weigh the risks as well as benefits and see a doctor who can assess whether they are a good candidate for the procedure, according to an ophthalmologist at UT Southwestern Medical Center.

    At UT Southwestern, we use a patient-specific approach to LASIK with technology that calculates the precise pattern of a patient’s eye, like a fingerprint, and adapts the treatment to those measurements. This level of customization is one of the keys to reducing the potential for side effects,” said William Waldrop, M.D., Assistant Professor in UT Southwestern’s Department of Ophthalmology.

    New guidelines proposed by the Food and Drug Administration would require physicians to provide better communication about the risks associated with LASIK, which can include dry eyes; visual phenomena such as glare or halos; decreased vision in low-light settings; eye pain; and temporary distortions in vision. Many of these side effects dissipate after three to six months. 

    Each year, an estimated 700,000 patients in the U.S. undergo LASIK to reduce their dependency on glasses or contact lenses. The procedure, which has been available in the U.S. since 1998, is fast, painless, and in most cases, provides improved vision for 10 years or longer.

    “From the beginning, LASIK outcomes have been outstanding, and we’ve continually improved the procedure to allow for a higher likelihood of better vision and higher quality vision,” Dr. Waldrop said. “Ultimately, though, the answer may be ‘no’ to LASIK, and sometimes that is the safest choice. LASIK isn’t always the best or only option for vision correction.”

    Dr. Waldrop said patients considering LASIK should focus first on choosing the right surgeon. UTSW ophthalmologists are skilled in a variety of vision correction surgeries, including advanced surface ablation and refractive lens exchange.

    “You want a surgeon who will take the time to do a thorough examination and pre-surgical workup to determine if it’s appropriate for your unique characteristics,” he said. “Has wearing contacts changed the surface of your eye? How thick is your cornea? What is the likelihood of your cornea taking on an irregular shape after surgery? Those are all factors that can impact the success of your surgery.

    “If you aren’t a suitable candidate for LASIK, you want your surgeon to be upfront with you and offer an alternative,” Dr. Waldrop said.

    About UT Southwestern Medical Center

    UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 24 members of the National Academy of Sciences, 18 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,900 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in more than 80 specialties to more than 100,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 4 million outpatient visits a year.

    [ad_2]

    UT Southwestern Medical Center

    Source link

  • خبير من مايو كلينك للرعاية الصحية يشرح لماذا داء الجَزْر ليس مجرد حرقة في المعدة

    خبير من مايو كلينك للرعاية الصحية يشرح لماذا داء الجَزْر ليس مجرد حرقة في المعدة

    [ad_1]

    لندن – داء الجَزْر المَعدي المريئي هو أحد أكثر اضطرابات الهضم شيوعًا حول العالم. يحدث عندما يعود الحمض من المعدة إلى المريء: يمكن للمعدة مقاومة الأحماض ولكن المريء أقل مقاومة للأحماض. جيمس إيست، دكتور الطب، طبيب الجهاز الهضمي في مايو كلينك للرعاية الصحية في لندن، يقول إن داء الجَزْر قد يكون شائعًا، ولكن قد تحدث مضاعفات إذا ظل مستمرًا وتُرِكَ دون علاج.

    [ad_2]

    Mayo Clinic

    Source link

  • 妙佑医疗中心专家解释为什么反流病不“只是”胃灼热?

    妙佑医疗中心专家解释为什么反流病不“只是”胃灼热?

    [ad_1]

    伦敦 — 胃食管反流病是世界上最常见的消化道疾病之一。当胃酸从胃部上升到食管时就会发生这种状况:胃能抗酸,但食管的抗酸能力却没有那么强。妙佑伦敦医疗中心的胃肠科医生James East(医学博士)说反流病虽然很常见,但如果长期不加以治疗,可能会出现严重的并发症。

    [ad_2]

    Mayo Clinic

    Source link

  • 70 Doctors-in-Training at The University of Queensland Ochsner Clinical School Receive White Coats

    70 Doctors-in-Training at The University of Queensland Ochsner Clinical School Receive White Coats

    [ad_1]

    Newswise — NEW ORLEANS – On Saturday, January 7, 2023, The University of Queensland Ochsner Clinical School held its 13th annual White Coat Ceremony, a rite of passage for medical students held to emphasize the importance of compassionate patient care from the start of medical training. During the event, 70 physicians-in-training received their white coats and were honored with Humanism in Medicine pins – a visual symbol displayed on the lapel of each white coat to remind students to keep empathy at the center of clinical practice.

    Yolangel (Yogi) Hernandez Suarez, MD MBA FACOG, Senior Associate Dean for Student Affairs at FIU Herbert Wertheim College of Medicine, served as the keynote speaker. Dr. Hernandez Suarez, a healthcare leader in Miami for over 20 years, has held positions in private, public, academic, and hospital settings. She spent her career building value for patients, providers, and learners through public- private partnerships, inclusive practice models, and community relationships.

    The ceremony concluded with a recitation of the Ochsner Clinical School Oath, which serves as the official start to the second phase of the UQ Ochsner Medical Degree program focused on clinical experiences.

    “The white coat is a symbol used to express and affirm a fundamental belief in a caring, professional medical system,” said Ronald Amedee, MD, Dean of Medical Education, Director of The University of Queensland Ochsner Clinical School. “Many patients now view the white coat as a ‘cloak of compassion’ and a symbol of the caring and hope they expect to receive from their physicians. The University of Queensland Ochsner Clinical School is proud to carry on this tradition and share in this momentous occasion as our students continue their journeys to become physicians.”

    Medical students from UQ Ochsner Clinical School who received their white coats are encouraged to participate in community projects facilitated by the Ochsner Medical Student Association (OMSA). Programs include Walk with a Future Doc, a national non-profit that encourages healthy physical activity in people of all ages; Ochsner’s “Save-A-Voice” ALS Voice Banking team, made up of students who volunteer their time to help patients with newly diagnosed ALS record their voice; and The UQ STAR mentorship program, in which the UQ Ochsner Clinical School students mentor a select cohort of high school seniors by teaching clinical examination skills and other medical knowledge.

    The modern-day White Coat Ceremony was revolutionized by Arnold P. Gold, MD, a teacher and pediatric neurologist at Columbia University for more than 40 years. Dr. Gold believed the symbolic gesture of handing white coats and reciting the Hippocratic Oath after four years of medical school was happening too late. He advocated for well-defined guidelines for expectations and responsibilities appropriate for the medical profession prior to the first day of training. This belief inspired the creation of the Arnold P. Gold Foundation, a nonprofit he began with his wife, Sandra Gold, EdD, and the expansion of what has become known as the White Coat Ceremony around the globe.

     

    A Unique Approach to Global Medical Education

    Established in 2009, the UQ Ochsner Clinical School is a unique four-year training, academic and clinical experience. Students gain exposure to global health concepts by experiencing both the Australian and American healthcare systems.  

    The first two years of medical school curriculum take place in Brisbane, Australia at UQ, which ranks among the world’s top 50 universities by U.S. News Best Global Universities Ranking. The final two years of clinical study are completed with the Ochsner Health – one of the largest independent academic medical centers in the United States – located in New Orleans, LA.

    Last year, UQ Ochsner Clinical School achieved a record 98% match rate through the National Residency Match Program. UQ Ochsner Clinical School students have moved on to train in every specialty at prestigious institutions across the country such as Johns Hopkins, Mayo Clinic, University of Pennsylvania, and University of Chicago.

    “The focus on global education is critically important for the future of medicine, and we are privileged to have this international partnership,” said Leonardo Seoane, MD, FACP, Executive Vice President and Chief Academic Officer, Ochsner Health. “At Ochsner, the patient is at the center of everything we do, so underscoring the importance of compassionate care to the next generation of doctors is crucial to helping communities here in Louisiana and beyond.”

    For more information on the UQ Ochsner Clinical School, visit https://ochsner.uq.edu.au

     

    ###

     

    About Ochsner Health

    Ochsner Health is an integrated healthcare system with a mission to Serve, Heal, Lead, Educate and Innovate. Celebrating 80 years, it leads nationally in cancer care, cardiology, neurosciences, liver and heart transplants and pediatrics, among other areas. Ochsner is consistently named both the top hospital and top children’s hospital in Louisiana by U.S. News & World Report. The not-for-profit organization is inspiring healthier lives and stronger communities. Its focus is on preventing diseases and providing patient-centered care that is accessible, affordable, convenient and effective. Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including over 700 clinical studies. It has more than 36,000 employees and over 4,600 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 47 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama and the Gulf South; and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls. In 2021, Ochsner Health treated more than 1 million people from every state and 75 countries. As Louisiana’s top healthcare educator, Ochsner Health and its partners educate thousands of healthcare professionals annually. To learn more, visit www.ochsner.org.

    [ad_2]

    Ochsner Health

    Source link

  • How Bitcoin Can Radically Improve The Healthcare System For Patients

    How Bitcoin Can Radically Improve The Healthcare System For Patients

    [ad_1]

    This is an opinion editorial by Robert Hall, a content creator and small business owner.

    Nothing is more critical to long-term health than having access to healthcare when needed. But every jurisdiction around the world implements this process differently. Many countries socialize the cost of healthcare through the government on a sliding scale from total government control to private market healthcare, with a sprinkle of government-provided health insurance for the poor and the elderly.

    In the United States, we primarily have a private healthcare system. If you have the money, you can purchase healthcare services from any service provider you like. But the problem in America isn’t a lack of healthcare providers; it is how healthcare services are paid for.

    [ad_2]

    Robert Hall

    Source link

  • Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Missourians

    Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Missourians

    [ad_1]

    Newswise — ST. LOUIS, MISSOURI – JANUARY 10, 2023 – Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Brenda Shields (R-St. Joseph) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. Last year alone, more than 5,560 individuals were diagnosed with breast cancer and more than 820 died of the disease in Missouri.

    “This legislation can make an immediate impact for thousands of people who require diagnostic or supplemental breast imaging yet are unable to afford it and often forego the tests,” said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen. “Everyone should be able to access the care they need and afford it, especially when it could mean the difference between a person’s life and death.”

    HB 575, introduced by Rep. Shields, would eliminate out-of-pocket costs for diagnostic and supplemental breast imaging (such as an MRI, ultrasound, diagnostic mammogram) when medically necessary. These exams can be extremely expensive and require people to pay high out-of-pocket costs – all before more expensive treatment even begins.

    Komen-commissioned study found the costs to patients range from $234 for a diagnostic mammogram to more than $1,021 for a breast MRI. The cost of the test prevents individuals in Missouri from getting the imaging they require, making it difficult to detect their breast cancer as early as possible. 

    An estimated 16 percent of people who receive annual screening mammograms nationwide get called back for diagnostic imaging. Additionally, these tests are often recommended for those who have previously been diagnosed with breast cancer and for some individuals who are considered at high-risk for breast cancer, making their out-of-pocket costs particularly burdensome to those individuals.

    “When the threat of breast cancer rears its head, women and their doctors need every tool available to for an accurate diagnosis,” said Rep. Shields. “Early detection is vital to protecting the women of Missouri – and insurance coverage of diagnostic mammograms should not stand in the way of Missourians’ access to this life-saving technology. This bill will save lives by ensuring treatment can begin as early as possible.”

    The use of breast cancer screening and follow-up diagnostics have led to significant increases in the early detection of breast cancer in the past 30 years. However, this is not true across all demographics. Evidence shows that Black and Hispanic breast cancer patients tend to be diagnosed at a later stage, perhaps due to delays in follow-up imaging after abnormal findings on an annual mammogram.

    More diagnostic and supplemental breast imaging is likely going to be needed due to “missed” breast cancers during the COVID-19 pandemic. Experts warn that missed mammograms could lead to more later-stage breast cancer diagnoses, once detected, so it is critically important that we increase access to affordable tests to those who medically require it.  

    About Susan G. Komen®

    Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

    [ad_2]

    Susan G. Komen

    Source link

  • UChicago Medicine, AdventHealth launch new joint venture to expand health services in western suburbs

    UChicago Medicine, AdventHealth launch new joint venture to expand health services in western suburbs

    [ad_1]

    Newswise — The University of Chicago Medicine and AdventHealth have closed on a transaction to form a joint venture called UChicago Medicine AdventHealth, which will combine the expertise and resources of both organizations to bring academic medicine to the western suburbs.

    The two organizations announced a definitive agreement to affiliate in September 2022, with plans for UChicago Medicine to acquire a controlling interest in AdventHealth’s Great Lakes Region, which includes its four Illinois hospitals in Bolingbrook, Glendale Heights, Hinsdale and La Grange along with a network of nearly 50 physicians’ offices and outpatient locations.

    The AdventHealth Great Lakes Region’s facilities will be co-branded as UChicago Medicine AdventHealth to build upon the complementary strengths of the two organizations, with UChicago Medicine’s national reputation as an academic health system and AdventHealth’s focus on delivering outstanding medical care in community settings.

    “With the launch of this affiliation, we are blessed to continue to build on the rich legacy of whole-person care and further our mission and commitment to making these communities healthier for years to come,” said Terry Shaw, president/CEO of AdventHealth.

    Under the new joint venture, which became official January 1, 2023, UChicago Medicine gains a controlling interest in AdventHealth’s Great Lakes Region. AdventHealth retains the remaining ownership and will continue to manage daily operations of all facilities. Both UChicago Medicine and AdventHealth will maintain their separate system-level governance and administrative structures.

    Physicians of UChicago Medicine and AdventHealth Great Lakes will partner and coordinate care across both organizations to deliver high-quality, value-based care. This collaboration also will lead to an excellent patient experience and improved outcomes for patients.

    “The biggest benefit of this partnership is to patients,” said Tom Jackiewicz, president of the University of Chicago Medical Center, the hub of the UChicago Medicine health system. “AdventHealth Great Lakes’ patients now will have seamless access to UChicago Medicine’s specialty and subspecialty care and the latest clinical trials without the commute.”

    “In the same vein, UChicago Medicine patients who live in the western suburbs will now have access to AdventHealth’s exceptional quality, community-based care,” said Thor Thordarson, president and CEO of AdventHealth’s Great Lakes Region. “Working together, we can accomplish more for our patients and communities, and our shared resources and expertise will mean a healthier future for the greater Chicagoland area.”

    Medical teams from both organizations will be working in the coming months to expand programs and services, recruit more physicians and deliver even better care. To lead that effort, Sandra Valaitis, MD, has been appointed UChicago Medicine’s Chief Physician for the affiliation. Valaitis currently serves as UChicago Medicine’s Section Chief of Gynecology and Reconstructive Pelvic Surgery and Vice Chair of Faculty Affairs.

    In her new position, she will be responsible for physician collaboration, clinical integration and program development for the new joint venture. She will be working closely with Bela Nand, MD, Chief Medical Officer at UChicago Medicine AdventHealth Hinsdale and La Grange, who will lead the clinical integration efforts for the AdventHealth Great Lakes Region facilities.

    “I am excited to work together with my colleagues at UChicago Medicine and AdventHealth to ensure we’re building bridges between organizations that will enable us to better connect care for patients — whether they’re seeing their long-time family doctor in the western suburbs or a sub-specialist in Hyde Park,” said Valaitis.

    The affiliation is the latest move for UChicago Medicine, an integrated academic health system that includes hospitals, outpatient clinics and physician practices throughout Chicagoland as well as in the suburbs and Northwest Indiana. UChicago Medicine has been working for many years on developing and strengthening a healthcare ecosystem for communities on the South Side and beyond. That includes plans to build Chicago’s first freestanding comprehensive cancer facility on its medical campus on the South Side, where cancer is the second-leading cause of death. It’s also building a 130,000-square-foot multispecialty ambulatory center in Crown Point to serve the growing population in Northwest Indiana. It is also collaborating with 12 community providers on the South Side Healthy Community Organization collaborative, which is working to improve access to quality care for more than 400,000 people who live on Chicago’s South Side.

    AdventHealth is a faith-based health system headquartered in Florida with more than 50 hospital campuses in nine states and more than 80,000 team members, 2,400 employed physicians and almost 18,000 medical staff providers across the organization. AdventHealth’s Great Lakes Region includes UChicago Medicine AdventHealth Bolingbrook, UChicago Medicine AdventHealth GlenOaks, UChicago Medicine AdventHealth La Grange and UChicago Medicine AdventHealth Hinsdale, which has been serving the community for more than 100 years, as well as nearly 50 primary and specialty practice locations and two multispecialty ambulatory centers. The Carol Stream and Woodridge ambulatory centers offer primary and specialty care providers, diagnostic imaging and lab services.

    [ad_2]

    University of Chicago Medical Center

    Source link

  • Paul Farmer Collaborative to Amplify Work and Honor Legacy of Global Health Champion

    Paul Farmer Collaborative to Amplify Work and Honor Legacy of Global Health Champion

    [ad_1]

    Newswise — A $50 million gift from Woburn, Mass.-based Cummings Foundation will build upon and amplify the work of the late Paul Farmer, a champion of global health. 

    The gift establishes the Paul Farmer Collaborative of Harvard Medical School and the University of Global Health Equity (UGHE) in Rwanda. It will be divided equally between the two institutions. 

    Farmer, a physician and medical anthropologist, was the Kolokotrones University Professor and chair of the Department of Global Health and Social Medicine in the Blavatnik Institute at HMS, chancellor of UGHE, and co-founder and chief strategist of PIH, an international health and human rights organization. He died on Feb. 21, 2022, at the age of 62, while teaching at UGHE, an initiative of PIH. 

    “During his all-too-brief time here with us, Paul was the vital physical link between Harvard and UGHE,” said Joyce Cummings, who co-founded Cummings Foundation with her husband, suburban Boston real estate magnate Bill Cummings. “In Paul’s absence, it is critical that we act to ensure that this bond and his work endure.” 

    “This gift will allow us to continue Paul’s transformative work and honor his vision to reshape health care delivery for marginalized populations and to connect HMS with the University of Global Health Equity,” said HMS Dean George Q. Daley. “This gift is a powerful reminder that as a global community, we are only as strong as the most vulnerable among us, which Paul understood better than anyone.” 

    The Paul Farmer Collaborative

    The gift is intended to build on Farmer’s legacy and enable researchers at both institutions to deepen their exploration of social medicine, a field focused on the many factors influencing a person’s health, and pursue fundamental questions about social determinants of health and humane caregiving. The overarching goal of the collaborative is to catalyze the development of sustainable, equitable health systems that improve health care delivery to underserved populations. 

    The program, named in Farmer’s honor, will build on existing multifaceted collaborations between HMS and UGHE. 

    Cummings Foundation’s gift, to be paid over 10 years, will fund:

    • Independent and collaborative research, teaching, and education at both institutions.
    • Exchange of students, postdoctoral trainees, and faculty between the two institutions.
    • An annual global conference and workshop on health equity, global health delivery, research, education, and social medicine.
    • An endowed Cummings Foundation Professorship of Global Health Equity at HMS to continue advancing Farmer’s ideals and objectives.
    • Clinical training opportunities for medical students and residents, with an initial focus on building surgical capacity and surgical health innovation in low-resource settings. Long-term, the training could expand to include other clinical specialties such as mental health, obstetrics, gynecology, pediatrics, internal medicine, dermatology, and anesthesiology. 

    The relationship between HMS and Rwanda has deep roots. In 2005, PIH was asked to help the Rwandan Ministry of Health fight HIV, improve maternal and child health, and bring integrated, high-quality health care to people in the nation’s rural districts. 

    Since then, Farmer and global health and social medicine and clinical faculty at HMS and affiliated hospitals have also collaborated with Rwandan health care providers and researchers on a number of efforts combining research, clinical innovation, and training. 

    In 2012, HMS faculty and collaborators from the Rwandan Ministry of Health launched an intensive global health delivery course at the Rwinkwavu Hospital Training Center,  modeled on the Global Health Delivery Intensive Program developed at Harvard. The HMS master’s program in global health delivery has hosted students from Rwanda, and has been adapted as a program at UGHE. And in 2022, a team from HMS and Rwanda won the National Institutes of Health Technology Accelerator Challenge for Maternal Health for a project to develop artificial intelligence tools that help community health workers identify patients at risk for surgical-site infections. 

    “This remarkably timely, generous, and transformative gift from Cummings Foundation will sustain and build upon the ongoing collaboration between our department and the University of Global Health Equity,” said Allan Brandt, interim head of the HMS Department of Global Health and Social Medicine and the Amalie Moses Kass Professor of the History of Medicine at HMS. “The Paul Farmer Collaborative will ensure that our faculties and students partner to extend the goal of global health equity and assure that those most in need receive the highest quality care.” 

    One of the latest academic and medical collaborations between the two institutions is the newly launched Center for Equity in Global Surgery at UGHE. The center aims to develop solutions to correct the imbalance in access to care through research and innovation, education and training, policy, advocacy, and global collaborations, according to a paper describing the launch of the center in early February2022. The paper, co-authored by Farmer and colleagues from HMS and UGHE, is one of Farmer’s last pieces of published research. 

    The Paul Farmer Collaborative will strengthen the efforts of the HMS Program in Global Surgery and Social Change and the UGHE Center for Equity in Global Surgery, an effort that the paper described as a vehicle for global surgery solutions developed in Africa through research, education, advocacy, and training. 

    In the days before Farmer died, he gave two remote talks at the University of Hawaii from the campus of UGHE, where he was excited to be doing rounds with the first class of third-year medical students at the school. One of his presentations was on his latest book, Fevers, Feuds, and Diamonds: Ebola and the Ravages of History, in which he discusses the complex social, historical, and economic context of the West Africa Ebola outbreak. Another was on the importance of focusing on equity and social justice to improve health, drawing heavily on examples of his collaborative work in Rwanda. In the question-and-answer periods of both talks, Farmer shared several lessons learned in his decades of work on global health equity. 

    “We need to shift the conversation to what we’re hearing from poor people,” Farmer said. “I hear people saying, we want schools for our children, we want clean water, we want jobs, and we’d like to have our kids go to places like the UGHE.” 

    He also described the kinds of things he often heard from people, including many who work in the field of global health. They often listed things they thought were not possible in places like rural Rwanda: you can’t treat cancer, you can’t have an ICU, you can’t build a hospital or a medical school, many people told him. 

    Farmer noted that he was speaking to his audience in Hawaii from a thriving academic medical center campus, built in a rural area in Rwanda that didn’t even have electricity just a few years ago. 

    “This place is blossoming,” Farmer said. “We need to stand up to people who say ‘you can’t do this,’ because it’s being done.” 

    Landmark funding

     To effect real change, collaboration must include material support, not just  symbolic solidarity, Farmer said. Empathy is essential, he noted, but it takes “staff, stuff, space, systems, and support” to deliver the promise of modern medicine to people everywhere. 

    In dollars and time commitment, this support from Cummings Foundation funds one of the most significant relationships that HMS has in Africa.

     “It is incredibly exciting to have a nearly 400-year-old institution collaborating at such a significant level with a seven-year-old institution,” said Joyce Cummings. “Meaningful international partnerships are essential to effectively teaching global health, so Harvard will benefit immensely from solidifying its relationship with a top-notch university in such a highly desirable locale for learning and teaching about global health delivery. And UGHE will enjoy enormous reputational benefits, affording it greater visibility to major international life sciences and pharma firms seeking appropriate sites for investment, operations, and collaboration.” 

    “UGHE is training a new generation of leaders who will bring together the best evidence and a strong commitment to equity to improve health systems in East Africa and beyond,” said Jim Yong Kim, co-founder of PIH and newly appointed successor to Farmer as chancellor of UGHE. “Cummings Foundation’s visionary gift will greatly facilitate the exchange of knowledge between students and faculty in Boston and Butaro. We are so grateful to Bill and Joyce Cummings, and we know that their gift will be transformative.” 

    Kim previously served as president of the World Bank and of Dartmouth College. Like Farmer, he earned his MD and PhD at HMS and served as chair of its Department of Global Health and Social Medicine.

    “Rwanda was our family’s home for many years, and it is where Paul left us,” said Farmer’s wife, Didi Bertrand Farmer. “I am honored that this collaboration between Harvard/HMS and PIH/UGHE bears Paul’s name in the pursuit of social justice and equity in health, to which he devoted his life. I am so thankful for the generosity of Bill and Joyce Cummings.”

    Created by PIH, UGHE was launched in 2015 with substantial support from Cummings Foundation, the Bill & Melinda Gates Foundation, and the Republic of Rwanda. The government donated land for the magnificent rural campus, plus major new roadways and improved access to water, electricity, and internet connectivity. 

    In addition to the new $50 million gift, Cummings Foundation has contributed $2 million to UGHE to construct a residential facility for visiting faculty on its campus in rural Butaro, Rwanda. The 10,000-square-foot structure will offer about 10 apartments and a faculty lounge to facilitate connections among full-time and visiting professors. 

    Support for UGHE has grown significantly in recent years, with the largest donations coming from Cummings Foundation and the Bill & Melinda Gates Foundation. Prior to this year, Cummings Foundation contributed more than $27.5 million to UGHE while the Gates Foundation donated more than $18.5 million to help establish the university’s flagship degree programs.

    In September, the Gates Foundation committed $50 million toward the Paul E. Farmer Scholarship Fund for UGHE, which will cover the tuition, room, board, and expenses of 3,000 students over the next 25 years. 

    With the new gift, Cummings Foundation also honors Larry Bacow, Harvard’s 29th president, who in June announced plans to step down from the role on June 30, 2023. 

    “Harvard is so grateful for Cummings Foundation’s support to carry on Paul Farmer’s important work,” said Bacow. “Through their thoughtful and generous philanthropy, Bill and Joyce have improved the lives of countless people throughout the world. This gift will build on their important work.” 

    “We are so pleased to honor the legacies of both Paul and Larry, two dear friends,” said Joyce Cummings. “Our hope is that this long-term funding will help to carry on their commitments to leadership and service on a global scale.” 

    Adapted from a Cummings Foundation news release.

    [ad_2]

    Harvard Medical School

    Source link

  • Patient-Reported Experience Measures Indicate How Well Healthcare Systems Meet the Needs of Patients

    Patient-Reported Experience Measures Indicate How Well Healthcare Systems Meet the Needs of Patients

    [ad_1]

    Newswise — Lawrenceville, NJ, USA—January 10, 2023. Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research—announced today the publication of a series of articles that promotes an understanding of patient-reported experience measures and their role in healthcare. The series was published in the January 2023 issue of Value in Health. Guest editors for the themed section were Axel Mühlbacher, PhD, Hochschule Neubrandenburg, Neubrandenburg, Germany, and Elly Stolk, PhD, EuroQol Research Foundation, Rotterdam, The Netherlands

    “The use of patient-reported measures in routine clinical settings is rapidly expanding because many healthcare systems are moving towards patient-centered care,” said Mühlbacher and Stolk in their opening editorial. “In addition to clinically reported outcome measures, the experience of the care process matters too. Patient-reported experience measures have become an important tool for policy makers who wish to understand how well healthcare delivery is aligned with patients’ goals.” 

    Compared with health preference research, patient-reported experience measures provide a fuller picture of how well a healthcare system meets the needs of patients by combining indicators at the individual and organizational level. The papers in the Value in Health themed section were intended to bring together current research on patient experience, patient-reported experience measures, patient journeys, patient preferences, and utilization of the data produced. Together, the studies illustrate the wide range of activities that contribute to patient-centered care and optimizing of the patient experience. 

    Mühlbacher and Stolk’s introductory editorial, “Patient-Reported Satisfaction, Experiences, and Preferences: Same but Different?” includes an overview of the topic and introduces the 5 articles in the series:

    1. Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids,” by Mimi Choon-Quinones, Dirk Hose, Zoltán Kaló, Tamás Zelei, Jean-Luc Harousseau, Brian Durie, Paul Keown, Mike Barnett, and Ivett Jakab
    2. Patient Expectations About Palliative Treatment for Symptomatic Spinal Metastases: A Qualitative Study,” by Roxanne Gal, Raphäele Charest-Morin, Jorrit-Jan Verlaan, Charles Fisher, Hester Wessels, Helena Verkooijen, and Anne Versteeg
    3. Developing Patient-Centered Real-World Evidence: Emerging Methods Recommendations From a Consensus Process,” by Elisabeth Oehrlein, Silke Schoch, Mehmet Burcu, Julia McBeth, Jennifer Bright, Chris Pashos, Richard Willke, Thelma Love, T. Joseph Mattingly II, and Eleanor Perfetto on behalf of the Patient Centered Real-World Evidence Working Group
    4. Enhancing Patient-Centricity of Real-World Data Research: An Exploratory Analysis Using the Patient Experience Mapping Toolbox,” by Elisabeth Oehrlein, Mehmet Burcu, Silke Schoch, and Laura Gressler
    5. A Data-Driven Approach to Support the Understanding and Improvement of Patient’s Journeys: A Case Study Using Electronic Health Records of an Emergency Department,” by Farhood Rismanchian, Sara Kassani, Seyed Shavarani, and Young Lee

    Delivering what patients want requires a deep understanding of the diversity of patient preferences, as obtained from preference research, which in the process of care must be paired with ways for patients to communicate their needs and wants and that avoid use of strategies they find disempowering. Decision aids and shared decision-making processes need to have adequate room for patients to influence decisions about the care they receive, which needs to be evaluated in context of the received care.

    “A view that emerges from the papers,” concluded Mühlbacher and Stolk, “is that we are still on a path to unlock the potential of patient experience research. Papers in this themed section reflect a significant investment in the development of protocols and support for such studies. However, major challenges remain in leveraging existing data and how to supplement it with targeted additional data collection to understand the difference between the actual and the optimal patient experience.”

    Additional information on ISPOR’s work on patient engagement can be found on the Society’s Patient Engagement in HEOR webpage.

    ###

     

    ABOUT ISPOR
    ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
    Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  
     

    ABOUT VALUE IN HEALTH
    Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2021 impact factor score is 5.156 and its 5-year impact factor score is 6.779. Value in Health is ranked 9th of 88 journals in health policy and services, 18th of 109 journals in healthcare sciences and services, and 50th of 381 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
    Website  | Twitter (@isporjournals)

    [ad_2]

    ISPOR–The Professional Society for Health Economics and Outcomes Research

    Source link

  • Families with Food Insecurity Have Greater Health Care Expenditures

    Families with Food Insecurity Have Greater Health Care Expenditures

    [ad_1]

    Newswise — WINSTON-SALEM, N.C. – Jan. 9, 2023 – Food insecurity, which is the limited or uncertain availability of nutritionally adequate and safe food, impacts about 10.2% of U.S. households, according to the U.S. Department of Agriculture Economic Research Service. In families with children in the home, food insecurity is even higher, at 12.5%.

    Previous studies have shown an association between food insecurity and individual health care expenditures, but there is little research on how food insecurity impacts families’ health care use.

    Now, researchers at Wake Forest University School of Medicine are reporting the results of a new study that shows food-insecure families have higher health care expenditures than families that are food secure.

    The study was released today in the January issue of Health Affairs.

    “We know that food insecurity has a negative impact on individual health outcomes,” said Deepak Palakshappa, M.D., associate professor of general internal medicine at Wake Forest University School of Medicine and principal investigator of the study. “But we need a better understanding of the financial implications on families and health care expenditures.”

    In the retrospective study, Palakshappa’s team sought to determine the association between a family’s food insecurity over the course of one year and their health care expenditures throughout the following year. Researchers analyzed data from the 2016 and 2017 Medical Expenditure Panel Survey, a large-scale survey conducted annually by the Agency for Healthcare Research and Quality that is representative of the U.S. population. The survey collects information from U.S. medical providers about health care services, health insurance, expenditures and sociodemographic characteristics.

    The team collected data on 14,666 individuals from 6,621 families and found that food-insecure families had 20% greater total health care expenditures than food-secure families, an annual difference of about $2,456.

    “We found that food insecurity in 2016 was associated with increased care expenditures in 2017 among families regardless of insurance coverage type,” Palakshappa said.

    The results also have significant implications for any potential programs or policies aimed at addressing food insecurity.

    “Interventions that address food insecurity in one or more specific family members may also provide benefits to others in the home,” Palakshappa said. “And there’s a potential financial benefit for insurers to invest in these programs.”

    Palakshappa’s team also found that 1 in 5 families had more than one insurance plan, making it challenging to determine the full financial benefit of food insecurity interventions in households with mixed insurance coverage.

    “More parents are enrolling their children in Medicaid or CHIP instead of their employer-sponsored health insurance because of increased out-of-pocket expenses,” Palakshappa said. “However, the expansion of public subsidies such as the Supplemental Nutrition Assistance Program or child tax credits can alleviate food insecurity.”

    Palakshappa said additional research is needed to evaluate how addressing food insecurity at an individual patient visit may affect the health outcomes and health care utilization of other family members.

    [ad_2]

    Wake Forest University School of Medicine

    Source link

  • Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month

    Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month

    [ad_1]

    Newswise — Bausch + Lomb, a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national non-profit organization with the vision of curing glaucoma, today announced the U.S. launch of ‘Screen, Protect, Cure,’ a campaign designed to provide educational resources and raise awareness of glaucoma, a leading cause of irreversible blindness, during Glaucoma Awareness Month.1

    “We are proud to collaborate with Glaucoma Research Foundation to provide critical information about this serious eye disease and underline the negative toll it can have if left untreated,” said Christina Ackermann, president, Ophthalmic Pharmaceuticals, Bausch + Lomb. “Glaucoma can affect individuals of all ages and only half of those affected are aware they have it, so it’s important that we share risk factors, how to get tested and what treatment options are available. Through ‘Screen, Protect, Cure,’ we hope to help support patients in every step of their treatment journey.”1

    During the month of January, Glaucoma Awareness Month, Bausch + Lomb and GRF will share educational resources to educate individuals who may be at risk for glaucoma and empower them to take an informed and active role in their eye health. The campaign also features a fundraising challenge that will match every dollar raised up to $20,000 in support of GRF research for a potential cure for glaucoma.

    “Glaucoma Awareness Month provides a great opportunity to share information about this sight-threatening disease and remind people there are steps they can take to help preserve their vision,” said Thomas M. Brunner, president & CEO, GRF. “Visiting an eye care provider on an annual basis and paying attention to visual function are the best things someone can do to avoid the irreversible damage from glaucoma. Although there is currently no cure, our fight to prevent visual disability is ongoing, and we are grateful for the collaboration of organizations, such as Bausch + Lomb, who share this commitment with us.”

    People interested in participating in the fundraising challenge or testing their knowledge about glaucoma can take an interactive quiz and learn more at glaucoma.org/screen-protect-cure.

    About Glaucoma Glaucoma is a complex, progressive disease that occurs when excessive eye pressure or other causes lead to damage of the optic nerve. The optic nerve is responsible for the communication of information between the eye and brain. Damage to the optic nerve can lead to severe vision loss, and in the worst case, blindness. As one of the leading causes of preventable blindness, glaucoma affects about three million people in the United States, but if caught early, it is possible to help slow and potentially prevent vision loss.1,2

    About Glaucoma Research Foundation Founded in 1978, GRF is focused on its mission to cure glaucoma through innovative research, leading the industry as a nonprofit organization. Building teams of collaborating researchers and scientists over the years, all sharing the common goal of finding a cure – GRF is committed to raising awareness, spreading the word and encouraging others to achieve this shared goal. For more information visit, https://www.glaucoma.org/, and follow Glaucoma Research Foundation on FacebookInstagramLinkedIn, and Twitter.

    About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with Bausch + Lomb on TwitterLinkedInFacebook and Instagram.

    References

    1. U.S. Centers for Disease Control and Prevention. Retrieved from https://www.cdc.gov/visionhealth/resources/features/glaucoma-awareness.html. Reviewed on Nov. 8, 2022.
    2. Mayo Clinic. Retrieved from https://www.mayoclinic.org/diseases-conditions/glaucoma/symptoms-causes/syc-20372839. Reviewed on Nov. 8, 2022.

    Source: BusinessWire

     

    [ad_2]

    Glaucoma Research Foundation

    Source link

  • Sports Medicine Experts Available to Discuss Damar Hamlin’s Injury

    Sports Medicine Experts Available to Discuss Damar Hamlin’s Injury

    [ad_1]

    Newswise — Loyola Medicine sports medicine and cardiology experts are available to discuss the incident involving Buffalo Bills safety Damar Hamlin, who suffered a cardiac arrest on the field following a tackle during Monday night’s football game against the Cincinnati Bengals.   

    Loyola Medicine’s team of sports medicine specialists provides comprehensive, integrated orthopaedic and sports medicine care. Built on a tradition of excellence and innovation, Loyola Medicine’s comprehensive heart and vascular program brings together specialists from all aspects of cardiology and vascular care. Specialists treat a wide variety of cardiac and vascular conditions and diseases while offering nationally acclaimed comprehensive heart and vascular services. 

    [ad_2]

    Loyola Medicine

    Source link

  • Study shows peer messaging tool can be successfully implemented in the nursing workforce

    Study shows peer messaging tool can be successfully implemented in the nursing workforce

    [ad_1]

    Newswise — A tool developed at Vanderbilt University Medical Center to address disrespectful workplace behaviors through trained peer-to-peer messaging can be successfully implemented in the nursing workforce with the appropriate support, according to a new study published in the January 2023 issue of .

    The first author of the article, “Implementation of Peer Messengers to Deliver Feedback: An Observational Study to Promote Professionalism in Nursing,” is Cindy Baldwin, MS, RN, CPHRM, senior associate for the Department of Pediatrics and School of Nursing at the Vanderbilt Center for Patient and Professional Advocacy.

    Prior research shows that unprofessional behaviors in health care settings lead to unhappy, less motivated workers and poorer outcomes for patients and families, Baldwin said. She and other researchers evaluated the feasibility of implementing for staff nurses the Co-Worker Observation System (CORS), a tool developed at VUMC in 2013. Prior to the study, CORS had been implemented for doctors and advanced practice providers at Vanderbilt, but not for staff nurses, Baldwin said.

    “We thought this was a unique opportunity to be able to give nurses an opportunity to self-regulate, as shared governance models highly support this concept,” Baldwin said. “Creating a vision for respect and inclusion for all team members aligns with organizations’ values and the nursing code of ethics.”

    Researchers implemented CORS for staff nurses at VUMC and two other academic medical centers — Keck Medicine of the University of Southern California (including USC Verdugo Hills Hospital and Norris Cancer Center) and University of Iowa Health Care — using a project bundle with 10 essential implementation elements.

    CORS promotes addressing professional behavior in the moment, but if that doesn’t happen, co-workers can use an electronic documentation system to document the observation. In the study, those reports were screened through natural language processing software, coded by trained CORS coders using the Martinez taxonomy, then referred to a trained nurse messenger who is carefully selected to be a peer, based on role and tenure.  The nurse messenger shares the observation with the nurse that offended the person who reported the incident. The name of the reporter is withheld.

    The study considered 590 reports from the three sites from Sept. 1, 2019 to Aug. 31, 2021. Most reports included more than one unprofessional behavior — a total of 1,367 unprofessional behaviors were recorded, then mapped to existing categories in the CORS system. Most unprofessional behaviors — 48.8% — were related to issues in clear and respectful communication. Another 33.3% were related to performing duties/tasks that are part of a role. A total of 6.8% were related to appropriate medical care; 5.9% to professional integrity; and 5.2% a report of concern or possibly egregious.

    Baldwin also noted that 92% of all nurses in the study’s database never received a CORS report about their behavior.

    Baldwin said the beauty of the peer-reporting system is it allows a trained peer messenger to resolve the issue with the nurse that trigged the report, and the incident is not reported to nursing leadership or human resources unless required by policy or law or requiring investigation. Most peer reports are delivered at face value, without investigation, realizing that there are two sides to every story.

    CORS data collected over 10 years show that most people listen to peer criticism and self-correct. She noted that much unprofessional behavior is not rooted in the workplace, but rather outside life stressors.

    “We want to make sure that people hear or understand how they’re being perceived, whether it’s a one-time thing or it’s a pattern, without immediately going to progressive discipline.”

    Baldwin cautioned that simply implementing a peer-to-peer reporting system isn’t enough; messengers must be trained, and the correct reporting infrastructure and leadership support must be in place. The study found that nurses would deliver CORS messages to their peers with the correct training.

    Other VUMC authors of the paper are Alice Krumm, DNP, RN, CNOR; Heather Davidson, PhD; Lynn Webb, PhD; Thomas Doub, PhD; and William Cooper, MD, MPH.

    “The findings of this study really highlight the fact that professionals will respond if we approach them in respectful, nonjudgmental ways,” said Cooper, who leads the Center for Patient and Professional Advocacy.

    Cooper expressed appreciation for VUMC nursing leadership for supporting the innovative project, which has already drawn interest from health systems around the country. “This work continues a longstanding partnership between our center and Vanderbilt’s nursing leadership in identifying innovative ways to promote professionalism,” he said.

    Executive Chief Nursing Officer Marilyn Dubree, MSN, RN, NE-BC, FAAN, noted that VUMC recently received its fourth Magnet designation from the American Nurses Credentialing Center, in part because of its commitment to shared governance.

    “Every nurse at Vanderbilt has a voice, and CORS is an innovative peer-reporting model that strengthens that voice,” she said. “I am excited about the possibilities as we expand the use of this tool to further empower our nurses.”

    [ad_2]

    Vanderbilt University Medical Center

    Source link

  • O nutricionista da Mayo Clinic responde: seria um smoothie de frutas uma boa opção para substituir uma refeição?

    O nutricionista da Mayo Clinic responde: seria um smoothie de frutas uma boa opção para substituir uma refeição?

    [ad_1]

    Newswise — PHOENIXUm smoothie comum é uma bebida feita com uma mistura de frutas ou vegetais. Há muitas maneiras de preparar um. Embora eles forneçam vários benefícios à saúde, beber muitos smoothies pode afetar negativamente a sua saúde. Eles podem adicionar muitas calorias inesperadas à dieta, especialmente quando um smoothie é uma bebida que pode equivaler a uma refeição. Lorraine Fye, nutricionista da Mayo Clinic, dá algumas dicas sobre como consumir smoothies de frutas de uma forma inteligente. 

    Smoothies são bebidas deliciosas e fáceis de fazer. Mas, eles são bons para a sua saúde? 

    “Eu diria que essa é uma maneira muito fácil de consumir muitas frutas e vegetais benéficos para a sua saúde. Em um pequeno copo, você pode obter muitos nutrientes”, diz Fye. 

    Mas o excesso, mesmo de uma coisa boa, pode ser prejudicial. 

    “Um smoothie que pode ser prejudicial à saúde seria um que talvez tenha só frutas ou com muito suco de frutas, com a adição de muito açúcar e não muito equilibrado”, diz Fye. 

    Um smoothie pode ser delicioso e ainda ser saudável. Você só precisa incluir os ingredientes certos. 

    “O smoothie saudável: esse é o equilíbrio que estamos realmente procurando. O que você precisa é de bons carboidratos, boas proteínas e gorduras boas e saudáveis,” ela diz. 

    Depois de encontrar o equilíbrio e o sabor certos, esse smoothie pode ser uma coisa boa. 

    “É muito bom tomar um smoothie todos os dias. Ele pode substituir uma refeição de maneira conveniente, desde que você se certifique de que realmente está substituindo a refeição. A quantidade de calorias deve ser suficiente”, diz Fye. 

    Receitas de smoothies: 

    ### 

    Jornalistas: um vídeo com qualidade para transmissão (1:00) está disponível no final da publicação em inglês na Rede de Notícias da Mayo Clinic. Lembrem-se de incluir “Cortesia: Rede de Informações da Mayo Clinic.” 

    Sobre a Mayo Clinic A Mayo Clinic é uma organização sem fins lucrativos comprometida com a inovação na prática clínica, educação e pesquisa, fornecendo compaixão, conhecimento e respostas para todos que precisam de cura. Visite a Rede de Notícias da Mayo Clinic para obter outras notícias da Mayo Clinic.  

    [ad_2]

    Mayo Clinic

    Source link

  • يستجيب اختصاصي التغذية في Mayo Clinic: هل عصير الفاكهة خيار بديل جيد للوجبات؟

    يستجيب اختصاصي التغذية في Mayo Clinic: هل عصير الفاكهة خيار بديل جيد للوجبات؟

    [ad_1]

    الشراب المخفوق التقليدي (السموذي) هو عبارة عن مشروب مصنوع من خليط الفواكه أو الخضراوات، ويمكن تحضيره بعدة طرق مختلفة. على الرغم من فوائده الصحية العديدة، فإن الإفراط في تناول المشروبات المخفوقة (السموذي) بمعدلات كبيرة قد يؤثر سلبًا على صحتك. إذ إنه قد يضيف الكثير من السعرات الحرارية غير المتوقعة، لا سيما عند تناوله مع وجبات طعام. لورين فاي، اختصاصي النُّظم الغذائية لدى مايو كلينك، لديها بعض الطرق البسيطة للتعامل بذكاء مع شراب الفاكهة المخفوقة (السموذي).

    [ad_2]

    Mayo Clinic

    Source link

  • China Approves Merck’s Molnupiravir for Emergency Use, Regulator Says

    China Approves Merck’s Molnupiravir for Emergency Use, Regulator Says

    [ad_1]

    China’s top drug regulator said Friday that it approved Merck & Co.’s Molnupiravir for emergency use on Thursday, as the country grapples with waves of infections after Beijing abruptly reversed its stringent Covid-19 restrictions earlier this month.

    The National Medical Products Administration said it is requiring the approval holder to continue relevant research, complete conditional requirements and submit follow-up research results in a timely manner, according to a statement posted on its website Friday.

    Write to Singapore Editors at singaporeeditors@dowjones.com

    Corrections & Amplifications

    This item was corrected at 0856 GMT to reflect China’s top drug regulator said it approved Merck & Co.’s Molnupiravir for emergency use on Thursday. The original version incorrectly said the approval came on Wednesday in the first paragraph.

    [ad_2]

    Source link

  • Best of Proviso Township to Host its “Holiday Lights and Love Caravan” in Front of Loyola University Medical Center

    Best of Proviso Township to Host its “Holiday Lights and Love Caravan” in Front of Loyola University Medical Center

    [ad_1]

    WHAT: A “Holiday Lights and Love Caravan” vehicle parade to provide holiday cheer for patients and staff.

    WHEN: December 30, 2022, at 5:30 pm.

    WHO: The Best of Proviso Township Organization. Organizers expect 50 to 75 vehicles, including fire trucks and police cars. Organizers will gather at 4:30 pm in the parking lot of the John J. Madden Mental Health Center, 1200 S 1st Ave, Maywood, IL to decorate their vehicles.

    WHERE: Loyola University Medical Center 2160 S. 1st Ave. Maywood, IL The caravan will travel along the frontage road in front of the hospital.

    Media should enter at Entrance 1 off of Roosevelt Road, south of the John J. Madden Mental Health Center. Follow the frontage road south to 2nd street where the caravan will begin. The parade will travel in front of the hospital. Media can park in the North Lot next to the John J. Madden Mental Health Center, South of Roosevelt in the designated “LOYOLA HOSPITAL PARKING ONLY” posts.

    [ad_2]

    Loyola Medicine

    Source link

  • Delaying antibiotics for neutropenic fever may not affect survival of cancer inpatients

    Delaying antibiotics for neutropenic fever may not affect survival of cancer inpatients

    [ad_1]

    Newswise — December 29, 2022 — In cancer patients with neutropenic fever, delaying antibiotic treatment past 60 minutes from the time of fever detection does not reduce the short-term chance of survival, according to a study in the American Journal of Medical Quality. The journal is published in the Lippincott portfolio by Wolters Kluwer.

    Neutropenia—low levels of white blood cells called neutrophils, which fight infection—develops in more than 80% of patients who receive chemotherapy for a blood cancer. It occurs because chemotherapy destroys neutrophils along with tumor cells.

    A fever in a patient with neutropenia is considered a medical emergency, according to Adam Binder, MD, of Thomas Jefferson University Hospital in Philadelphia, and colleagues. The fever signals a severe decrease in neutrophils and therefore a compromised ability of the immune system to ward off infections. Neutropenic fever is defined as a temperature of at least 101°, or a sustained temperature of at least 100.4° for an hour or more.

    The Infectious Disease Society of America and the American Society of Clinical Oncology have both published guidelines for treating outpatients who have neutropenic fever. Both organizations call for administering an intravenous antibiotic within 60 minutes after the fever is detected. The recommendation about antibiotics is also often applied to the treatment of hospital inpatients, but there’s no clear evidence that’s appropriate.

    Comparing inpatients who did or did not receive antibiotics during the recommended treatment window

    Dr. Binder and his colleagues looked back at data on 187 patients at their hospital who had developed neutropenic fever. Their main goal was to see whether delays in antibiotic treatment affected short-term survival.

    Only 14% of patients received antibiotics within 60 minutes of developing neutropenic fever. Their survival rate 6 months later wasn’t significantly better than the survival rate of patients who received antibiotics later than recommended.

    Further analysis identified several factors that had a statistically significant association with the risk of death:

    • Patients with insurance had a 72% lower risk of death than those without insurance
    • Patients with at least one other major medical condition had a 2.7 times greater risk of death than those with blood cancer alone
    • Patients who were treated with antibiotics within 40 minutes actually had a 5.7 greater risk of death than those who didn’t receive antibiotics so quickly

    A possible explanation for the last finding, the researchers say, is that patients who received antibiotics within 40 minutes “had other symptoms that yielded a concerning clinical picture, thus leading to a timelier administration of antibiotics, but ultimately a worse clinical outcome.”

    Guidelines for treatment of outpatients may not apply to hospitalized patients

    Even a delay of more than 4 hours wasn’t long enough to affect survival, Dr. Binder and his colleagues determined. That result is consistent with information from previous studies of inpatients, they say.

    The authors believe existing treatment guidelines are appropriate for patients with neutropenic fever who are treated in a physician’s office or an emergency department, but other factors must be considered for patients who have been admitted to a hospital. “Unlike neutropenic fever patients presenting to the emergency department, where true time to antibiotic administration may often be many hours or even days before arrival, a few hours long [delay] in the hospital may not be sufficiently long enough to cause significant patient harm.”

    Read [Delay in Time to Antibiotics for De Novo Inpatient Neutropenic Fever May Not Impact Overall Survival for Patients With a Cancer Diagnosis]

    ###

    About the American Journal of Medical Quality

    The American Journal of Medical Quality (AJMQ) is the official journal of the American College of Medical Quality. AJMQ is focused on keeping readers informed of the resources, processes, and perspectives contributing to quality health care services. This peer-reviewed journal presents a forum for the exchange of ideas, strategies, and methods in improving the delivery and management of health care.

    About the American College of Medical Quality

    The American College of Medical Quality (ACMQ) is the organization for healthcare professionals responsible for providing leadership in quality and safety outcomes, who want or need the tools, experience, and expertise to improve the quality and safety of patient care. Membership in ACMQ provides a gateway to resources, programs, and professional development opportunities and a greater recognition of quality issues by the entire healthcare field.

    About Wolters Kluwer

    Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

    Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

    Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

    For more information, visit www.wolterskluwer.com, follow us on TwitterFacebookLinkedIn, and YouTube.

    [ad_2]

    Wolters Kluwer Health: Lippincott

    Source link

  • 您在这里:抽烟者的戒烟指南

    您在这里:抽烟者的戒烟指南

    [ad_1]

    如果您是一名抽烟者,您可能正处于想要戒烟的阶段,但需要一份指南,指引您如何从抽烟的”这里”到达不抽烟的”那里”。以下是明尼苏达州曼凯托妙佑区域医疗系统的精神病学家Patrick Bigaouette医学博士关于如何开始您的无烟之旅的建议。

    [ad_2]

    Mayo Clinic

    Source link